Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf, genetically unmodified T-cell therapeutics for ...
The initiative will build and power the infrastructure required to digitize and deliver impactful AI-driven pathology solutions to patients and caregivers.
The Isambard-AI Supercomputer located at the National Composites Center in Bristol, UK, aims to be the one of the fastest 10 supercomputers in the world.